Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2003
07/15/2003US6593119 Core 2 β-1,6-N-acetylglycosaminyltransferase gene
07/15/2003US6593112 Polynucleotides encoding fibroblast growth factor 15
07/15/2003US6593109 Culturing cells containing DNA sequences under the control of a regulatory sequence capable of directing expression; useful in treating bone defects, healing bone injury and wounds
07/15/2003US6593108 Nucleic acid molecule encoding a melanin-concentrating hormone receptor 2 polypeptide
07/15/2003US6593105 Vector comprising a nucleic acid insert; alteration of amino acids within the helix-1 region; inability to convert to a disease-associated form; use in prophylaxis/gene therapy for neurodegenerative diseases
07/15/2003US6592910 Methods of treating clinical diseases with isoflavones
07/15/2003US6592904 Atomizing liquid solutions of the macromolecules, drying the droplets, and collecting the particles; process control; especially for proteins, a nucleic acids, and a high molecular weight polysaccharides.
07/15/2003US6592892 Flushable disposable polymeric products
07/15/2003US6592890 Conveyance of anti-infective activity to wound dressings
07/15/2003US6592879 Sacrificial enzyme substrate system, an enzyme inhibitor system or mixtures or combinations thereof, where the composition reduces skin irritation due to enzyme activity.
07/15/2003US6592877 Compounds and methods for immunotherapy and diagnosis of tuberculosis
07/15/2003US6592876 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
07/15/2003US6592873 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids
07/15/2003US6592868 Produced by hybridoma having ATCC Accession Number HB 10916
07/15/2003US6592865 Increasing vasoconstriction using angiotensin II potentiated with angiotesin 1-9
07/15/2003US6592862 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
07/15/2003US6592814 Lactoferrin microbiocidal coatings
07/15/2003CA2262269C Treatment of skeletal disorders
07/15/2003CA2245938C Combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
07/15/2003CA2208047C Increasing creatine and glycogen concentration in muscle
07/15/2003CA2139864C Use of a calcium carbonate based porous material as support for a growth factor in the preparation of a bioabsorbable implant
07/15/2003CA2122717C Hemoglobins as drug delivery agents
07/15/2003CA2095889C Low caloric density enteral formulation designed to reduce diarrhea in tube-fed patients
07/10/2003WO2003056339A1 Screening methods and the use of agents identified using the same
07/10/2003WO2003056332A1 Diagnostic for scleroderma
07/10/2003WO2003056014A1 Regulation of human mono (adp-ribosyl) transferase-like protein
07/10/2003WO2003056013A1 TGF-β-SPECIFIC COVALENTLY CLOSED ANTISENSE MOLECULE
07/10/2003WO2003056012A1 A system for stable expression of sirnas in mammalian cells
07/10/2003WO2003056011A2 Therapeuticum and prophylacticum for malignant diseases using phenotype suppression
07/10/2003WO2003056010A2 An antisense strategy to modulate estrogen receptor response (er. alpha. and/or er. beta.)
07/10/2003WO2003055997A1 Genomic sequences encoding dendritic cell expressed s-adenosyl homocysteine hydrolase like molecules
07/10/2003WO2003055995A2 Lipase genes and proteins
07/10/2003WO2003055992A2 A method for the establishment of a pluripotent human blastocyst-derived stem cell line
07/10/2003WO2003055983A2 Targeted retrograde gene delivery to motor neurons
07/10/2003WO2003055981A2 Methods of modulating heme oxygenase-1 expression and treating heme oxygenase-1 mediated conditions
07/10/2003WO2003055980A2 Il-17 like molecules and uses thereof
07/10/2003WO2003055917A2 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours
07/10/2003WO2003055916A2 Adiponectin fragments and conjugates
07/10/2003WO2003055915A2 Human netrin receptor and uses thereof
07/10/2003WO2003055913A2 Secreted protein
07/10/2003WO2003055912A2 Secreted proteins
07/10/2003WO2003055911A2 Cystine-knot fold protein
07/10/2003WO2003055910A1 Beta-amyloid binding factors and inhibitors thereof
07/10/2003WO2003055909A1 Regulation of human fatty acid binding protein
07/10/2003WO2003055908A2 Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases
07/10/2003WO2003055907A1 Tumour peptide antigen derived from the human cd19 protein
07/10/2003WO2003055906A1 Modified bacterial surface layer proteins
07/10/2003WO2003055901A1 Novel peptide sy
07/10/2003WO2003055531A2 A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis
07/10/2003WO2003055524A1 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method
07/10/2003WO2003055521A1 Remedies for mild recognition deflict
07/10/2003WO2003055516A1 Pecam-1 modulation
07/10/2003WO2003055512A1 Liquid composition of factor vii polypeptides
07/10/2003WO2003055511A1 Liquid composition of modified factor vii polypeptides
07/10/2003WO2003055510A1 Therapy for growth hormone induced insulin resistance in juveniles with growth disorders
07/10/2003WO2003055509A1 Agonists and antagonists of bromix for the treatment of metabolic disorders
07/10/2003WO2003055508A1 Composition for the treatment of renal failure or gastric dysfunction of e.g. premature or neonatal mammals
07/10/2003WO2003055507A1 Remedies for anorexia or lifestyle-related diseases and method of screening the same
07/10/2003WO2003055505A2 Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders
07/10/2003WO2003055499A1 Use of sulfated glycosaminoglycans for establishing effective labor in women
07/10/2003WO2003055480A1 Products for use in immunosuppressive therapy containing lipoic acid and a calcineurin inhibitor
07/10/2003WO2003055466A1 Microemulsion preconcentrate
07/10/2003WO2003055463A1 Composition comprising at least an oxazolin for inhibiting langerhans cell migration, and uses thereof
07/10/2003WO2003055462A2 Composition comprising at least an alkanolamide for inhibiting langerhans cell migration, and uses thereof
07/10/2003WO2003055443A2 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
07/10/2003WO2003055442A2 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi)
07/10/2003WO2003055440A2 Compositions and methods for the treatement of immune related diseases
07/10/2003WO2003055439A2 Her2/neu target antigen and use of same to stimulate an immune response
07/10/2003WO2003055324A1 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis
07/10/2003WO2003041694A3 Use of compounds comprising iodine, strontium and ascorbic acid as well as either bismuth, zinc or potassium in the treatment of aids
07/10/2003WO2003039437A3 Orally administered pharmaceutical preparation comprising liposomically encapsulated paclitaxel
07/10/2003WO2003035107A8 Enzyme inhibitors for inactivating allergens
07/10/2003WO2003033677A3 Dimerized growth factor and materials and methods for producing it
07/10/2003WO2003024992A3 HUMAN AND MOUSE β-DEFENSINS, ANTIMICROBIAL PEPTIDES
07/10/2003WO2003023015A3 Method for expression of small antiviral rna molecules within a cell
07/10/2003WO2003020203A3 Hydrogenated castor oil dispersed in a lipid for pharmaceutically elegant topical ointments
07/10/2003WO2003010140A3 Hepatitis c virus polymerase inhibitors with heterobicyclic structure
07/10/2003WO2003007880A3 Inhibition of behab cleavage and primary central nervous system (cns) tumors
07/10/2003WO2003004511A3 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
07/10/2003WO2003002765A3 Methods for the diagnosis of cancer based on the obcam and ntm genes
07/10/2003WO2003002175A8 Enhanced systemic absorption of intradermally delivered substances
07/10/2003WO2002102412A3 Selective inhibition of intracellular amyloid-beta neurotoxicity in human neurons
07/10/2003WO2002100345A3 Vaccines, immunotherapeutics and methods of using the same
07/10/2003WO2002090520A3 Toll/interleukin-1 receptor adaptor protein (tirap)
07/10/2003WO2002083060A3 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs
07/10/2003WO2002074956A3 Dopaminergic neuronal survival-promoting factors and uses thereof
07/10/2003WO2002072788A3 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses
07/10/2003WO2002063008A3 Intracellular signaling molecules
07/10/2003WO2002059267A3 Constitutively desensitized g protein-coupled receptors
07/10/2003WO2002046409A3 Proteins and nucleic acids encoding same
07/10/2003WO2002046229A3 Novel proteins and nucleic acids encoding same
07/10/2003WO2002043570A3 METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES
07/10/2003WO2002040672A3 Compositions and methods relating to breast specific genes and proteins
07/10/2003WO2002040541A3 Transporters and ion channels
07/10/2003WO2002040538A8 Regulation of human nmda receptor
07/10/2003WO2002038764A3 Il-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage
07/10/2003WO2002032939A3 Secreted proteins and their uses
07/10/2003WO2002028408A9 Compositions and methods for the transport of biologically active agents across cellular barriers
07/10/2003WO2002020464A8 Benzene tricarboxylic acid amides as insulin receptor activators
07/10/2003WO2002018581A3 G-protein coupled receptors
1 ... 1812 1813 1814 1815 1816 1817 1818 1819 1820 1821 1822 1823 1824 1825 1826 1827 1828 1829 1830 1831 1832 ... 3163